Your browser doesn't support javascript.
loading
Patient Experience of Lichen Planus: A Qualitative Exploration of Signs, Symptoms, and Health-Related Quality of Life Impacts.
Mahon-Smith, Aoife; Clifford, Molly; Batish, Anjali; Sharp, Rosie; Panter, Charlotte; Naujoks, Christel; Schruf, Eva; Compagno, Nicolò; Moreno, Santiago G.
Afiliación
  • Mahon-Smith A; Patient-Centered Outcomes, Adelphi Values Ltd, Bollington, Cheshire, UK. aoife.mahon-smith@adelphivalues.com.
  • Clifford M; Patient-Centered Outcomes, Adelphi Values Ltd, Bollington, Cheshire, UK.
  • Batish A; Patient-Centered Outcomes, Adelphi Values Ltd, Bollington, Cheshire, UK.
  • Sharp R; Patient-Centered Outcomes, Adelphi Values Ltd, Bollington, Cheshire, UK.
  • Panter C; Patient-Centered Outcomes, Adelphi Values Ltd, Bollington, Cheshire, UK.
  • Naujoks C; Novartis Pharma AG, Basel, Switzerland.
  • Schruf E; Novartis Pharma GmbH, Nürnberg, Germany.
  • Compagno N; Novartis Pharma AG, Basel, Switzerland.
  • Moreno SG; Novartis Pharma AG, Basel, Switzerland.
Dermatol Ther (Heidelb) ; 13(9): 2001-2017, 2023 Sep.
Article en En | MEDLINE | ID: mdl-37505393
ABSTRACT

INTRODUCTION:

Lichen planus (LP) is an inflammatory skin disorder that can present in various forms across the body, including lesions on the skin (cutaneous LP [CLP]), scalp (lichen planopilaris [LPP]), and mucosal regions (mucosal LP [MLP]). Qualitative exploration of the patient experience of LP, notably symptoms and impacts on health-related quality of life (HRQoL), is limited. A scarcity of research was also identified relating to emotional wellbeing impacts of CLP patients. Two qualitative studies were conducted with LP patients to address these gaps.

METHODS:

Study 1 consisted of exit interviews conducted with a subset of adult patients with MLP (n = 5), CLP (n = 4), and LPP (n = 4) enrolled in an LP clinical study in the United States (US) to explore the patient experience. Study 2 consisted of independent qualitative interviews conducted with adult CLP patients (n = 13) from the US and Germany to further explore impacts on emotional wellbeing.

RESULTS:

Exit interviews found that itch , pain, and skin lesions were most frequently reported as signs/symptoms of LP. Itch and skin lesions were experienced across all LP subtypes, while pain was only reported by CLP and MLP patients. These signs/symptoms impacted HRQoL including emotional wellbeing (frustration, embarrassment), daily activities (oral hygiene, clothing options), social functioning (intimacy, social activities), and physical functioning (chewing/swallowing, opening/moving mouth). Impacts on activities of daily living (ADL) and physical functioning were mostly experienced by MLP patients. Independent qualitative interviews, which further explored impacts of CLP on patients' emotional wellbeing, identified frustration, worry, sadness, embarrassment, and depression as the most frequently experienced.

CONCLUSION:

The findings contribute to the literature by providing qualitative insights into signs/symptoms and HRQoL impacts of LP, from the adult patient perspective. The findings also highlight the importance of considering assessment of HRQoL impacts in future clinical LP research, particularly impacts on emotional wellbeing when selecting instruments for assessment of HRQoL in the CLP population. TRIAL REGISTRATION NCT04300296.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Qualitative_research Idioma: En Revista: Dermatol Ther (Heidelb) Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Prognostic_studies / Qualitative_research Idioma: En Revista: Dermatol Ther (Heidelb) Año: 2023 Tipo del documento: Article